Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Population Disequilibrium as Promoter of Adaptive Explorations in Hepatitis C Virus

  • García-Crespo, Carlos|||0000-0001-6561-5389
  • Gallego, Isabel
  • Soria Benito, María Eugenia|||0000-0002-4719-3351
  • de Ávila, Ana Isabel
  • Martínez-González, Brenda|||0000-0002-4482-5181
  • Vázquez-Sirvent, Lucía
  • Lobo-Vega, Rebeca|||0000-0002-4882-6763
  • Moreno del Olmo, Elena|||0000-0002-2301-4558
  • Gómez, Jordi
  • Briones Llorente, Carlos|||0000-0003-2213-8353
  • Gregori i Font, Josep|||0000-0002-4253-8015
  • Quer, Josep|||0000-0003-0014-084X
  • Domingo, Esteban
  • Perales Viejo, Celia|||0000-0003-1618-1937
Replication of RNA viruses is characterized by exploration of sequence space which facilitates their adaptation to changing environments. It is generally accepted that such exploration takes place mainly in response to positive selection, and that further diversification is boosted by modifications of virus population size, particularly bottleneck events. Our recent results with hepatitis C virus (HCV) have shown that the expansion in sequence space of a viral clone continues despite prolonged replication in a stable cell culture environment. Diagnosis of the expansion was based on the quantification of diversity indices, the occurrence of intra-population mutational waves (variations in mutant frequencies), and greater individual residue variations in mutant spectra than those anticipated from sequence alignments in data banks. In the present report, we review our previous results, and show additionally that mutational waves in amplicons from the NS5A-NS5B-coding region are equally prominent during HCV passage in the absence or presence of the mutagenic nucleotide analogues favipiravir or ribavirin. In addition, by extending our previous analysis to amplicons of the NS3- and NS5A-coding region, we provide further evidence of the incongruence between amino acid conservation scores in mutant spectra from infected patients and in the Los Alamos National Laboratory HCV data banks. We hypothesize that these observations have as a common origin a permanent state of HCV population disequilibrium even upon extensive viral replication in the absence of external selective constraints or changes in population size. Such a persistent disequilibrium-revealed by the changing composition of the mutant spectrum-may facilitate finding alternative mutational pathways for HCV antiviral resistance. The possible significance of our model for other genetically variable viruses is discussed.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy

  • Llorens-Revull, Meritxell|||0000-0002-8671-8907
  • Costafreda Salvany, Maria Isabel|||0000-0002-3114-3034
  • Rico, Angie
  • Guerrero Murillo, Mercedes|||0000-0002-5556-2460
  • Soria, Maria Eugenia
  • Píriz-Ruzo, Sofía
  • Vargas-Accarino, Elena|||0000-0002-2521-0368
  • Gabriel-Medina, Pablo|||0000-0003-3079-6364
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Riveiro Barciela, Mar|||0000-0001-9309-2052
  • Perales Viejo, Celia|||0000-0003-1618-1937
  • Quer, Josep|||0000-0003-0014-084X
  • Sauleda, Silvia|||0000-0001-7343-9557
  • Esteban Mur, Juan Ignacio|||0000-0001-5085-917X
  • Bes, Marta|||0000-0001-6103-072X
HCV CD4+ and CD8+ specific T cells responses are functionally impaired during chronic hepatitis C infection. DAAs therapies eradicate HCV infection in more than 95% of treated patients. However, the impact of HCV elimination on immune responses remain controversial. Here, we aimed to investigate whether HCV cure by DAAs could reverse the impaired immune response to HCV. We analyzed 27 chronic HCV infected patients undergoing DAA treatment in tertiary care hospital, and we determined the phenotypical and functional changes in both HCV CD8+ and CD4+ specific T-cells before and after viral clearance. PD-1, TIM-3 and LAG-3 cell-surface expression was assessed by flow cytometry to determine CD4+ T cell exhaustion. Functional responses to HCV were analyzed by IFN-Ɣ ELISPOT, intracellular cytokine staining (IL-2 and IFN-Ɣ) and CFSE-based proliferation assays. We observed a significant decrease in the expression of PD-1 in CD4+ T-cells after 12 weeks of viral clearance in non-cirrhotic patients (p = 0.033) and in treatment-naive patients (p = 0.010), indicating a partial CD4 phenotype restoration. IFN-Ɣ and IL-2 cytokines production by HCV-specific CD4+ and CD8+ T cells remained impaired upon HCV eradication. Finally, a significant increase of the proliferation capacity of both HCV CD4+ and CD8+ specific T-cells was observed after HCV elimination by DAAs therapies. Our results show that in chronically infected patients HCV elimination by DAA treatment lead to partial reversion of CD4+ T cell exhaustion. Moreover, proliferative capacity of HCV-specific CD4+ and CD8+ T cells is recovered after DAA's therapies.